IMVAHA Trial
Cross-source consensus on IMVAHA Trial from 1 sources and 5 claims.
1 sources · 5 claims
Uses
Comparisons
Other
Other
Highlighted claims
- IMVAHA includes both a cross-sectional health survey and a randomised crossover clinical trial. — Improving menstrual and vaginal health for all (IMVAHA): protocol for a randomised cross-over trial assessing the impact of menstrual products on the vaginal microbiome of women aged 18–35 years in Cameroon, Peru and Switzerland
- The trial assigns participants to use pads, tampons, and menstrual cups for two cycles each in random order. — Improving menstrual and vaginal health for all (IMVAHA): protocol for a randomised cross-over trial assessing the impact of menstrual products on the vaginal microbiome of women aged 18–35 years in Cameroon, Peru and Switzerland
- The clinical trial is designed to study longitudinal microbiome changes linked to specific menstrual products. — Improving menstrual and vaginal health for all (IMVAHA): protocol for a randomised cross-over trial assessing the impact of menstrual products on the vaginal microbiome of women aged 18–35 years in Cameroon, Peru and Switzerland
- The trial is registered at ClinicalTrials.gov under NCT06646185 and is planned for January to December 2026. — Improving menstrual and vaginal health for all (IMVAHA): protocol for a randomised cross-over trial assessing the impact of menstrual products on the vaginal microbiome of women aged 18–35 years in Cameroon, Peru and Switzerland
- Because the crossover design makes each participant their own control, the trial does not require a dedicated control group. — Improving menstrual and vaginal health for all (IMVAHA): protocol for a randomised cross-over trial assessing the impact of menstrual products on the vaginal microbiome of women aged 18–35 years in Cameroon, Peru and Switzerland